Skip to main content

Table 2 Newcastle-Ottawa scoring of studies assessing efficacy

From: Utility of posaconazole therapeutic drug monitoring and assessment of plasma concentration threshold for effective prophylaxis of invasive fungal infections: a meta-analysis with trial sequential analysis

Study Representativeness of the exposed cohort Selection of the non-exposed cohort Ascertainment of exposure Outcome of intferest was not present at start Comparability (score 0,1 or 2) Assessment of outcome Sufficient follow-up of outcome Adequacy of follow up of cohorts Score
Thakuria, L., et al. NA 1 1 1 1 1 1 1 7/9
Vanstraelen, K., et al. 1 1 1 1 1 0 1 1 7/9
Park, W. B., et al. 1 1 1 1 1 1 NA 0 6/9
Cornely, O. A., et al. 1 1 1 1 2 1 1 1 9/9
Hummert, S. E., et al. NA 1 0 1 1 0 1 1 5/9
Chae, H., et al. 1 1 1 1 1 1 1 1 8/9
Maertens, J., et al. 1 1 1 1 1 1 1 1 8/9
Duarte, R. F., et al. 1 1 1 1 1 NA 1 1 7/9
Desplanques, P. Y., et al. NA 1 1 1 1 1 1 1 7/9
Bourdelin, M., et al. 1 1 1 1 1 1 1 1 8/9
Gross, B. N., et al. 1 1 1 1 1 1 1 1 8/9
Cattaneo, C., et al. NA 1 0 1 1 NA 1 1 5/9
Tonini, J., et al. 1 1 1 1 1 1 1 1 8/9
Ross, A. L., et al. NA 1 1 1 1 1 1 1 7/9
Pavan, L., et al. NA 1 1 1 1 NA 1 1 6/9
Hoenigl, M., et al. 1 1 1 1 1 1 1 1 8/9
Eiden, C., et al. 1 1 1 1 0 1 1 1 7/9
Shields, R. K., et al. 1 1 1 1 1 1 1 1 8/9
Fanci, R., et al. 1 1 1 1 1 0 1 1 7/9
Bryant, A. M., et al. NA 1 1 1 1 1 1 1 7/9
Welzen, M. E., et al. 1 1 1 1 1 0 1 1 7/9
Lebeaux, D., et al. NA 1 1 1 1 1 1 1 7/9
Sengar 1 1 1 1 0 1 1 1 7/9
Döring 1 1 1 1 1 1 1 1 8/9
Liebenstein 1 1 NA 1 2 1 NA 1 7/9
Tverdek 1 1 NA 1 1 1 NA 1 6/9
  1. NA not available